U.S. Over-the-Counter Glucose Biosensors Market Growth, Size, Trends & Analysis 2034
U.S. Over-the-Counter Glucose Biosensors Market Growth, Size, Trends Analysis – By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jul-2025 | Report ID: HLCA25232 | Pages: 1 - 259 | Formats*: |
| Category : Healthcare | |||
U.S. Over-the-Counter Glucose Biosensors Market Introduction and Overview
According to SPER Market Research, the U.S. Over-the-Counter Glucose Biosensors Market is estimated to reach USD 335.07 million by 2034 with a CAGR of 11.75%.
The report includes an in-depth analysis of the U.S. Over-the-Counter Glucose Biosensors Market, including market size and trends, product mix, Applications, and supplier analysis. The U.S. Over-the-Counter Glucose Biosensors was valued at USD 110.32 million in 2024 and is expected to grow at a CAGR of 11.75% from 2025 to 2034. Some of the primary drivers driving market expansion are the rising prevalence of diabetes and prediabetes, the shift towards preventive healthcare, and athletes' increased utilisation of glucose biosensors. Furthermore, the country's aging population contributes to this trend because this age group is more susceptible to chronic conditions like diabetes, increasing the demand for effective solutions like glucose biosensors.
By End User Insights
Homecare dominated the market in 2024, accounting for the largest revenue share, and is expected to grow the fastest over the forecast period due to the rising prevalence of diabetes among the elderly and the growing demand for convenient, patient-centric healthcare solutions. OTC glucose biosensors, which allow patients to monitor their blood glucose levels without a prescription, are in high demand among those managing diabetes at home.
The use of these devices in the homecare segment is aided by advances in sensor technology that have enhanced accuracy, ease of use, and affordability. Similarly, the availability of OTC glucose biosensors has lowered obstacles for underprivileged communities, especially those with limited access to healthcare facilities.
Regional Insights
The Northeast region has taken a leading position in the U.S. Over-the-Counter Glucose Biosensors market. This leadership is attributed to a dense network of advanced healthcare facilities, high per-capita healthcare expenditures, a notable prevalence of diabetes and pre-diabetes, and the early adoption of wearable and continuous glucose monitoring (CGM) technologies—elements that are particularly prominent in the Northeast. This is further bolstered by robust FDA regulation and reimbursement policies.
Market Competitive Landscape
The U.S. Over-the-Counter Glucose Biosensors Market is dominated by established players such as Abbott, Medtronic, Roche Diagnostics, Dexcom Private Limited as well as a number of small and medium-sized companies because of their superior technology, significant worldwide presence, healthcare solution innovation, diagnostics leadership, and substantial R&D initiatives.
Recent Developments:
Abbott gained FDA approval in June 2024 for its two new over-the-counter continuous glucose monitoring systems, Libre Rio and Lingo. Lingo is aimed at consumers looking to better their health, whereas Libre Rio is intended for those aged 18 and up who have Type 2 diabetes and do not take insulin. Both systems use Abbott's sophisticated Freestyle Libre technology to improve glucose management and overall health.
In March 2024, Dexcom gained FDA approval for Stelo, the first over-the-counter glucose biosensor for persons with Type 2 diabetes who do not need insulin. This innovation improves access to continuous glucose monitoring technologies in the country.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By End User |
| Regions covered | West, Midwest, Northeast, Southwest, Southeast |
| Companies Covered | Abbott, Covaris, LLC, Dexcom, Intricon Corporation, Johnson & Johnson Services, Inc, Koninklijke Philips N.V, Masimo, Medtronic, Molecular Devices, LLC, PerkinElmer Inc, Quanterix. |
Key Topics Covered in the Report
- U.S. Over-the-Counter Glucose Biosensors Market Size (FY’2021-FY’2034)
- Overview of U.S. Over-the-Counter Glucose Biosensors Market
- Segmentation of U.S. Over-the-Counter Glucose Biosensors Market by End User (Healthcare Professional Offices, Specialty Clinics, Homecare)
- Statistical Snap of U.S. Over-the-Counter Glucose Biosensors Market
- Expansion Analysis of U.S. Over-the-Counter Glucose Biosensors Market
- Problems and Obstacles in U.S. Over-the-Counter Glucose Biosensors Market
- Competitive Landscape in the U.S. Over-the-Counter Glucose Biosensors Market
- Details on Current Investment in U.S. Over-the-Counter Glucose Biosensors Market
- Competitive Analysis of U.S. Over-the-Counter Glucose Biosensors Market
- Prominent Players in the U.S. Over-the-Counter Glucose Biosensors Market
- SWOT Analysis of U.S. Over-the-Counter Glucose Biosensors Market
- U.S. Over-the-Counter Glucose Biosensors Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs2.2.Market size estimation2.2.1.Top-down and Bottom-up approach2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats5.2.PESTEL Analysis5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape5.3.PORTERs Five Forces5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry5.4.Heat Map Analysis
6.Competitive Landscape
6.1. U.S. Over-the-Counter Glucose Biosensors Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U.S. Over-the-Counter Glucose Biosensors Market
7. U.S. Over-the-Counter Glucose Biosensors Market, By End-User (USD Million) 2021-2034
7.1.Healthcare Professional Offices (HCPs)7.2.Specialty Clinics7.3.Homecare
8. U.S. Over-the-Counter Glucose Biosensors Market, (USD Million) 2021-2034
8.1. U.S. Over-the-Counter Glucose Biosensors Market Size and Market Share
9. U.S. Over-the-Counter Glucose Biosensors Market, By Region, (USD Million) 2021-2034
9.1.West9.2. Midwest9.3. Northeast9.4. Southwest9.5. Southeast
10.Company Profile
10.1.Abbott10.1.1.Company details10.1.2.Financial outlook10.1.3.Product summary10.1.4.Recent developments10.2.Covaris, LLC.10.2.1.Company details10.2.2.Financial outlook10.2.3.Product summary10.2.4.Recent developments10.3.Intricon Corporation10.3.1.Company details10.3.2.Financial outlook10.3.3.Product summary10.3.4.Recent developments10.4.Johnson & Johnson Services, Inc10.4.1.Company details10.4.2.Financial outlook10.4.3.Product summary10.4.4.Recent developments10.5.Koninklijke Philips N.V10.5.1.Company details10.5.2.Financial outlook10.5.3.Product summary10.5.4.Recent developments10.6.Masimo10.6.1.Company details10.6.2.Financial outlook10.6.3.Product summary10.6.4.Recent developments10.7.Medtronic10.7.1.Company details10.7.2.Financial outlook10.7.3.Product summary10.7.4.Recent developments10.8.Molecular Devices, LLC10.8.1.Company details10.8.2.Financial outlook10.8.3.Product summary10.8.4.Recent developments10.9.PerkinElmer Inc10.9.1.Company details10.9.2.Financial outlook10.9.3.Product summary10.9.4.Recent developments10.10.Quanterix10.10.1.Company details10.10.2.Financial outlook10.10.3.Product summary10.10.4.Recent developments10.11.Others
11.Conclusion
12.List of Abbreviations
13.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
U.S. Over-the-Counter Glucose Biosensors Market projected to reach USD 335.07 by 2034, growing at a CAGR of 11.75 % during the forecast period.
U.S. Over-the-Counter Glucose Biosensors Market from 2025. The Market is expected to reach USD 335.07 by 2034, at a CAGR of 11.75% during the forecast period.
U.S. Over-the-Counter Glucose Biosensors Market CAGR of 11.75% during the forecast period.
You can get the sample pages by clicking the link - Click Here
U.S. Over-the-Counter Glucose Biosensors Market size is USD 335.07 from 2025 to 2034.
U.S. Over-the-Counter Glucose Biosensors Market covered By End User
The North America is anticipated to have the highest Market share in the U.S. Over-the-Counter Glucose Biosensors Market .
"
Abbott, Covaris, LLC, Dexcom, Intricon Corporation, Johnson & Johnson Services, Inc, Koninklijke Philips N.V, Masimo, Medtronic, Molecular Devices, LLC, PerkinElmer Inc, Quanterix."
The report includes an in-depth analysis of the U.S. Over-the-Counter Glucose Biosensors Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
